Genetic Variation in the alpha 7 Nicotinic Acetylcholine Receptor is Associated with Delusional Symptoms in Alzheimer's Disease

R. Carson, David Craig, D. Hart, Stephen Todd, B. McCuinness, James Johnston, Francis O'Neill, C.W. Ritchie, Peter Passmore

Research output: Contribution to journalArticlepeer-review

39 Citations (Scopus)

Abstract

Psychotic symptoms are common in Alzheimer's disease (AD) and have a negative impact oil quality of life. It is suggested that psychotic symptoms may be attributed to genetic risk factors which are revealed during neurodegeneration. CHRNA7, the gene for the alpha 7 nicotinic acetylcholine receptor, has been associated with schizophrenia in linkage and association Studies. Hence we investigated single SNPs and haplotypes in CHRNA7 in relation to AD with psychosis in a large, well-characterised and previously described cohort within the Northern Ireland population. A significant association between delusions and the T allele of rs6494223 (P = 0.014, OR = 1.63, Cl 1.22-2.17) was found. This suggests that the alpha 7 receptor may be a suitable target for the treatment of AD with psychosis.
Original languageEnglish
Pages (from-to)377-384
Number of pages8
JournalNeuroMolecular Medicine
Volume10
Issue number4
DOIs
Publication statusPublished - Dec 2008

ASJC Scopus subject areas

  • Molecular Medicine
  • Cellular and Molecular Neuroscience
  • Neurology

Fingerprint

Dive into the research topics of 'Genetic Variation in the alpha 7 Nicotinic Acetylcholine Receptor is Associated with Delusional Symptoms in Alzheimer's Disease'. Together they form a unique fingerprint.

Cite this